Alterity Therapeutics Ltd
ASX:ATH
Alterity Therapeutics Ltd
ASX:ATH
Price:
0.0085
AUD
6.25%
Market Cap:
AU$92.4m
Balance Sheet
Balance Sheet Decomposition
Alterity Therapeutics Ltd
Alterity Therapeutics Ltd
Balance Sheet Decomposition is not available for
Alterity Therapeutics Ltd
Alterity Therapeutics Ltd
Balance Sheet
Alterity Therapeutics Ltd
Alterity Therapeutics Ltd
Currency: AUD
| Jun-1999 | Jun-2000 | Jun-2001 | Jun-2002 | Jun-2003 | Jun-2004 | Jun-2005 | Jun-2006 | Jun-2007 | Jun-2008 | Jun-2009 | Jun-2010 | Jun-2011 | Jun-2012 | Jun-2013 | Jun-2014 | Jun-2015 | Jun-2016 | Jun-2017 | Jun-2018 | Jun-2019 | Jun-2020 | Jun-2021 | Jun-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
0
|
4
|
7
|
4
|
3
|
30
|
21
|
10
|
0
|
0
|
4
|
5
|
9
|
6
|
13
|
34
|
35
|
29
|
22
|
15
|
14
|
9
|
28
|
35
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
5
|
9
|
6
|
13
|
34
|
35
|
0
|
0
|
0
|
0
|
9
|
0
|
0
|
|
| Cash Equivalents |
0
|
4
|
7
|
4
|
3
|
30
|
21
|
10
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
29
|
22
|
15
|
14
|
0
|
28
|
35
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
2
|
4
|
7
|
0
|
5
|
3
|
3
|
5
|
0
|
4
|
5
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
3
|
3
|
5
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
5
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
|
| Total Current Assets |
0
|
5
|
7
|
4
|
4
|
30
|
22
|
10
|
8
|
12
|
4
|
7
|
9
|
7
|
17
|
42
|
0
|
34
|
25
|
19
|
20
|
10
|
33
|
41
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Intangible Assets |
2
|
16
|
15
|
14
|
13
|
11
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
2
N/A
|
21
+1 035%
|
22
+7%
|
18
-21%
|
16
-7%
|
41
+153%
|
22
-46%
|
10
-53%
|
8
-26%
|
12
+52%
|
5
-61%
|
7
+48%
|
9
+33%
|
7
-19%
|
17
+133%
|
42
+144%
|
0
N/A
|
34
N/A
|
25
-25%
|
19
-26%
|
20
+6%
|
10
-50%
|
34
+239%
|
41
+23%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
1
|
1
|
1
|
0
|
1
|
0
|
2
|
1
|
2
|
3
|
1
|
1
|
3
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
2
|
0
|
0
|
0
|
0
|
1
|
1
|
2
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Current Liabilities |
0
|
0
|
1
|
1
|
1
|
3
|
3
|
2
|
2
|
2
|
1
|
2
|
2
|
2
|
3
|
4
|
3
|
2
|
2
|
3
|
3
|
3
|
3
|
6
|
|
| Long-Term Debt |
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
2
N/A
|
0
-92%
|
1
+513%
|
1
-1%
|
1
-37%
|
3
+375%
|
3
0%
|
2
-37%
|
2
+25%
|
2
-13%
|
1
-54%
|
2
+85%
|
2
+32%
|
2
-17%
|
3
+80%
|
4
+27%
|
0
N/A
|
2
N/A
|
2
-33%
|
3
+66%
|
3
+27%
|
3
-18%
|
3
+13%
|
6
+89%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
7
|
12
|
13
|
17
|
50
|
55
|
55
|
54
|
70
|
67
|
72
|
80
|
86
|
101
|
140
|
0
|
147
|
144
|
144
|
157
|
161
|
197
|
214
|
|
| Retained Earnings |
0
|
13
|
9
|
4
|
1
|
11
|
36
|
46
|
48
|
60
|
66
|
70
|
75
|
81
|
87
|
102
|
0
|
116
|
120
|
128
|
140
|
154
|
167
|
178
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
9
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
3
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
0
N/A
|
21
N/A
|
21
+3%
|
17
-22%
|
16
-5%
|
39
+145%
|
20
-49%
|
9
-55%
|
6
-36%
|
10
+76%
|
4
-62%
|
5
+39%
|
7
+33%
|
6
-19%
|
14
+149%
|
38
+170%
|
0
N/A
|
31
N/A
|
24
-24%
|
16
-32%
|
17
+3%
|
7
-57%
|
30
+326%
|
35
+16%
|
|
| Total Liabilities & Equity |
2
N/A
|
21
+1 035%
|
22
+7%
|
18
-21%
|
16
-7%
|
41
+153%
|
22
-46%
|
10
-53%
|
8
-26%
|
12
+52%
|
5
-61%
|
7
+48%
|
9
+33%
|
7
-19%
|
17
+133%
|
42
+144%
|
0
N/A
|
34
N/A
|
25
-25%
|
19
-26%
|
20
+6%
|
10
-50%
|
34
+239%
|
41
+23%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
35
|
51
|
57
|
59
|
66
|
116
|
127
|
128
|
152
|
202
|
203
|
234
|
275
|
298
|
382
|
489
|
0
|
534
|
534
|
534
|
861
|
1 037
|
2 084
|
2 407
|
|
Switch to:
Switch to:
See Also
Discover More
